N. Lee

Warfarin and Royal Jelly Interaction

Joli D. Fermo, N. Lee, 2006, Pharmacotherapy.

Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort.

C. Quinn, G. Buchanan, Z. Rogers, 2008, Blood.

Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia.

C. Quinn, G. Buchanan, Z. Rogers, 2005, Blood.

Multiple loci are linked with anti‐red blood cell antibody production in NZB mice − comparison with other phenotypes implies complex modes of action

T. Vyse, J. Boyle, L. Fossati-Jimack, 2004, Clinical and experimental immunology.

Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing.

Cynthia Y. Truong, R. Gaur, L. Schroeder, 2017, Diagnostic microbiology and infectious disease.

Significant Toxicities Associated with Antiretroviral Therapy

T. Kanmaz, N. Lee, 2000 .

Introduction to a review series: the 2016 revision of the WHO classi fi cation of tumors of hematopoietic and lymphoid tissues

Harris, R. Advani, R. Siebert, 2016 .

Prevalence of intracardiac shunting in children with sickle cell disease and stroke.

C. Ramaciotti, C. Quinn, G. Buchanan, 2010, The Journal of pediatrics.

Drug Class Review: HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin: Final Report Update 5

S. Carson, M. E. Smith, N. Lee, 2009 .